Skip to main content
. 2021 Jun 14;15:11782234211022203. doi: 10.1177/11782234211022203

Figure 1.

Figure 1.

Flow diagram of the clinical utility of sentinel lymph node biopsy in guiding adjuvant treatment strategies in patients diagnosed with oestrogen receptor positive, clinically node negative breast cancer aged greater than 65 years.

ACTX indicates adjuvant chemotherapy; cALND, completion axillary lymph node dissection; cLN−, clinically lymph node negative; ER+, oestrogen receptor positive; HER2−, human epidermal growth factor receptor-2 negative; ODX, OncotypeDX Recurrence Score testing; SLNB, sentinel lymph node biopsy.